BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17192563)

  • 1. Role of thymulin or its analogue as a new analgesic molecule.
    Dardenne M; Saade N; Safieh-Garabedian B
    Ann N Y Acad Sci; 2006 Nov; 1088():153-63. PubMed ID: 17192563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
    Haddad JJ
    Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat.
    Safieh-Garabedian B; Dardenne M; Pléau JM; Saadé NE
    Br J Pharmacol; 2002 Jul; 136(6):947-55. PubMed ID: 12110619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymulin reverses inflammatory hyperalgesia and modulates the increased concentration of proinflammatory cytokines induced by i.c.v. endotoxin injection.
    Safieh-Garabedian B; Ochoa-Chaar CI; Poole S; Massaad CA; Atweh SF; Jabbur SJ; Saadé NE
    Neuroscience; 2003; 121(4):865-73. PubMed ID: 14580936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of interleukin-1 beta, nerve growth factor, and prostaglandin-E2 in the hyperalgesia induced by intraplantar injections of low doses of thymulin.
    Safieh-Garabedian B; Kanaan SA; Jalakhian RH; Jabbur SJ; Saadé NE
    Brain Behav Immun; 1997 Sep; 11(3):185-200. PubMed ID: 9417804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin-mediated regulation of nuclear factor-kappaB nuclear translocation and activation in the hippocampus of the central nervous system: modulation by intracerebroventricular treatment with thymulin and the immunomodulatory role of the IkappaB-alpha/pIkappaB-alpha pathway.
    Haddad JJ
    Neuroscience; 2009 Dec; 164(4):1509-20. PubMed ID: 19782726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymulin related peptide attenuates inflammation in the brain induced by intracerebroventricular endotoxin injection.
    Safieh-Garabedian B; Jabbur SJ; Dardenne M; Saadé NE
    Neuropharmacology; 2011; 60(2-3):496-504. PubMed ID: 21059360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A thymulin analogue peptide with powerful inhibitory effects on pain of neurogenic origin.
    Saadé NE; Atweh SF; Jabbur SJ; Dardenne M; Bach JF; Safieth-Garabedian B
    Neuroscience; 2003; 119(1):155-65. PubMed ID: 12763077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity.
    Talhouk RS; Saadé NE; Mouneimne G; Masaad CA; Safieh-Garabedian B
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):625-31. PubMed ID: 15276687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-kappaB in a rat model of neuropathic pain.
    Zhu J; Wei X; Feng X; Song J; Hu Y; Xu J
    Neurosci Lett; 2008 Mar; 433(1):33-7. PubMed ID: 18248895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the α7-nicotinic acetylcholine receptors in the anti-inflammatory action of the thymulin-related peptide (PAT).
    Safieh-Garabedian B; Oz M; Bey RM; Shamaa F; Ashoor A; El-Agnaf OM; Saadé NE
    Neuroscience; 2013 Oct; 250():455-66. PubMed ID: 23880090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased tumor necrosis factor-alpha and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: the effects of analgesic drugs.
    Bianchi M; Martucci C; Ferrario P; Franchi S; Sacerdote P
    Anesth Analg; 2007 Apr; 104(4):949-54. PubMed ID: 17377112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor.
    Napimoga MH; Souza GR; Cunha TM; Ferrari LF; Clemente-Napimoga JT; Parada CA; Verri WA; Cunha FQ; Ferreira SH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):313-21. PubMed ID: 17928570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory role of thymulin in lung diseases.
    Santos M; Henriques-Coelho T; Leite-Moreira A
    Expert Opin Ther Targets; 2010 Feb; 14(2):131-41. PubMed ID: 20055713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.
    D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Mattace Raso G; Cuzzocrea S; Loverme J; Piomelli D; Meli R; Calignano A
    Eur J Pharmacol; 2009 Jun; 613(1-3):54-9. PubMed ID: 19386271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of capsaicin sensitive primary afferents in thymulin-induced hyperalgesia.
    Saadé NE; Major SC; Jabbur SJ; Atweh SF; Kanaan SA; Safieh-Garabedian B
    J Neuroimmunol; 1998 Nov; 91(1-2):171-9. PubMed ID: 9846833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-mediated or direct effects of thymulin on the nervous system as assessed by pain-related behavior.
    Safieh-Garabedian B; Kanaan SA; Jabbur SJ; Saadé NE
    Neuroimmunomodulation; 1999; 6(1-2):39-44. PubMed ID: 9876233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia.
    Sommer C; Kress M
    Neurosci Lett; 2004 May; 361(1-3):184-7. PubMed ID: 15135924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting neuroinflammation for therapeutic intervention in neurodegenerative pathologies: a role for the peptide analogue of thymulin (PAT).
    Safieh-Garabedian B; Mayasi Y; Saadé NE
    Expert Opin Ther Targets; 2012 Nov; 16(11):1065-73. PubMed ID: 22861065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.